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Abstract
Summary The usage of FRAX® tool in Thailand and other countries was explored using Google Analytics data. Over the period
2010–2018, Thailand ranked 35th in the world for FRAX usage (the US is ranked first). Incorporation of FRAX into a national
osteoporosis guideline in Thailand appears to have increased its usage.
Purpose To document access to the web-based FRAX® tool and specifically its access in Thailand between 2010 and 2018.
Methods A descriptive retrospective study using data from Google Analytics that provides numerical and geographical infor-
mation on internet access to the FRAX tool website worldwide.
Result In Thailand, Bangkok is the highest ranked site for FRAX access with more than 20,000 usage sessions since 2010 (3.6
usage session per 1000 population) followed by Khon Kaen and Chiang Mai. It has been accessed from within 76 out of 77
provinces (98.7%). There was a steady increase in access to FRAX from within Thailand of approximately 1000 usage sessions
per year between 2010 and 2016. After the FRAX fracture risk calculation was included in the national guideline for osteoporosis
management published in late 2016, the rate of increase in access was four-fold higher compared with the previous period. In
world ranking, the USA is the country with the most frequent access to the FRAX tool, whereas Thailand was ranked 35th in the
world. There were weak but significant correlations between the absolute number of FRAX sessions and population size (r =
0.165, p = 0.011) and land area (r = 0.375, p < 0.001).
Conclusion Access to the FRAX tool website is increasing in Thailand. The incorporation of FRAX into national guidelines, in
parallel to the adoption of osteoporosis fracture prevention into national policy, has had a rapid and significant impact on its use.
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Electronic supplementary material The online version of this article
(https://doi.org/10.1007/s11657-019-0613-2) contains supplementary
material, which is available to authorized users.
* Eugene V McCloskey
e.v.mccloskey@sheffield.ac.uk
1 Department of Orthopaedic Surgery, Faculty of Medicine, Siriraj
Hospital, Mahidol University, Bangkok 10700, Thailand
2 Academic Unit of Bone Metabolism, Department of Oncology and
Metabolism, TheMellanby Centre For Bone Research, University of
Sheffield, Sheffield, UK
3 MRC Lifecourse Epidemiology Unit, University of Southampton,
Southampton, UK
4 NIHR Southampton Biomedical Research Centre, University of
Southampton and University Hospital Southampton NHS
Foundation Trust, Southampton, UK
5 Centre for Metabolic Diseases, University of Sheffield Medical
School, Beech Hill Road, Sheffield S10 2RX, UK
6 Centre for Bone and Arthritis Research (CBAR), Sahlgrenska
Academy, University of Gothenburg, Gothenburg, Sweden
7 Mary MacKillop Institute for Health Research, Australian Catholic
University, Melbourne, Victoria, Australia
8 Region Västra Götaland, Geriatric Medicine Clinic, Sahlgrenska
University Hospital, Gothenburg, Sweden
9 Geriatric Medicine, Department of Internal Medicine and Clinical
Nutrition, Institute ofMedicine, Sahlgrenska Academy, University of
Gothenburg, Gothenburg, Sweden
10 Centre for Integrated Research into Musculoskeletal Ageing,
University of Sheffield Medical School, Sheffield, UK
Archives of Osteoporosis           (2019) 14:66 
https://doi.org/10.1007/s11657-019-0613-2
Introduction
Osteoporosis is one of the most common health problems in
older people, and its consequence, fragility fractures, can have
large impacts on the patient and their family [1]. There is an
increasing recognition of the need to intervene in patients at
high risk of fracture to decrease this fracture burden. The
FRAX® tool, developed by researchers at the University of
Sheffield, is used to evaluate individual fracture risk, based on
models that integrate clinical risk factors with or without ad-
ditional information provided by bonemineral density (BMD)
at the femoral neck [2]. It is freely and easily accessible to
healthcare workers with internet access (www.sheffield.ac.uk/
FRAX) and is also available as a paid for application on
smartphones. Individual data input and analysis takes less
than 1 min. FRAX calculates the 10-year probability of hip
fracture alone and of a major osteoporotic fracture (clinical
spine, forearm, hip, or shoulder fracture) in patients between
40 and 90 years of age. First released in 2008, FRAX currently
has models calibrated for 63 countries, comprising 69 popu-
lations (China, Singapore, and the USA have several ethnic-
specific models) and is available in 34 languages (Chinese and
Portuguese have 2 difference versions).
Whereas FRAX generates numerical fracture probabilities,
guidance is needed over the interpretation of these numbers so
that its clinical utility is driven by its incorporation into clinical
guidelines. To date, FRAX has been accepted in many osteo-
porosis guidelines in many regions of the world [3–7]. Given
disparities in fracture incidence, health policy, and budgetary
priorities, there is no international consensus on FRAX thresh-
olds either for the use of BMD or an intervention threshold to
be used as an indicator for treatment. In Thailand, FRAX was
first mentioned in a guideline launched in 2010 [8], wherein a
FRAX calculation was recommended when the femoral neck
BMD T-score was between − 1.0 and − 2.5, and osteoporosis
treatment initiated if the 10-year probability of fracture at hip
was ≥ 3% or major osteoporosis fracture ≥ 20%, mirroring
recommendations from the USA [9]. In 2010, in the absence
of a Thailand-specific FRAX model, it was recommended to
use the US Asian or Japanese models. Subsequently, a model
for Thailand was released in May 2013, but a new guideline
was not published until the end of 2016 [6]. In this latest
guideline, there are several indications for the initiation of
pharmacological treatment of osteoporosis. In general, for
postmenopausal osteoporosis and male idiopathic osteoporo-
sis age over 50 years, the indication can be one of the follow-
ing: presentation with a hip or vertebral fracture from low-
energy injury; lumbar spine BMD or femoral neck BMD or
total hip BMD showing T-score ≤ − 2.5; 10-year probability of
hip fracture by FRAX using Thai model (with BMD or with-
out) ≥ 3%.
The primary objective of this study was to assess the access
of the online FRAX tool from Thailand and other countries
across the period from 2010 to the end of 2018. A secondary
objective was to determine, if possible, the impact of guideline
incorporation in Thailand on FRAX usage.
Methods
This is a retrospective descriptive study using a free tool,
Google Analytics (https://analytics.google.com/analytics/
web/) [10, 11], to document access of users worldwide to the
FRAX calculator website. The survey of usage was conducted
between 15 February 2010 (the earliest date available in this
version of Google Analytics) and 31 December 2018. Data
tables were exported from Google Analytics in XLSX format
for further analysis. In Analytics, a session is the period of
time a user is actively engaged with FRAX tool website. All
usage data are associated with a session, whereas a bounce
rate captures the percentage of visits in which a person leaves
a FRAX website from the landing page without browsing any
further, i.e., enter and then leave the FRAX website without a
fracture risk calculation. The number of sessions per 1000
population was calculated from the total number of sessions
divided by the population size and multiplied by 1000. An
estimate of actual FRAX Busage sessions^ was calculated
from the total session multiplied by 1-bounce rate. The most
recent Thai population data in 2017 were acquired from the
Bureau of Registration Administration of Thailand [12].
FRAX usage was assessed in Thailand and compared with
patterns of use elsewhere in the world. The land area and
approximate 2018 population for each country were acquired
from the latest United Nations Population Division estimates,
with permission [13]. All graphs and table were made using
the Microsoft office 2016 package (Microsoft WA, USA).
Pearson correlation statistics were analysed using IBM SPSS
version 18.0 (SPSS Inc., Chicago, Illinois, USA).
Results
Usage of FRAX tool in Thailand
Thailand currently comprises 77 regions altogether (76 prov-
inces + Bangkok metropolitan). In the time period studied
here (15 February 2010–31 December 2018 inclusive), the
first two sessions of access to FRAX from Thailand, recorded
in this version of Google Analytics, were on 2 July 2010 from
Bangkok and Khon Kaen. Within 2010, FRAX had been
accessed from 17 of the Thailand regions and this increased
rapidly to a plateau of 69–71 regions in 2014 (Fig. 1). The
highest number of FRAX sessions arose from Bangkok,
followed by Khon Kaen and Chiang Mai (Table 1, Fig. 2).
The number of sessions rose steadily from 2010 to 2016, with
an approximate seven-fold increase over this time, reflecting
   66 Page 2 of 7 Arch Osteoporos           (2019) 14:66 
an average increase in session rate of 1098 per year. In 2017,
there was an apparent acceleration in FRAX session access so
that over the last two years there has been an average increase
of 4079 sessions per year. In terms of sessions recorded on the
FRAX website during the period of this study, Thailand is
ranked 35 out of 239 countries or dependencies (Table 2). A
fully detailed account of FRAX access from Thailand since
2010 is provided in Supplementary Table 1.
Worldwide usage of FRAX tool
Usage of FRAX elsewhere in the world was assessed to pro-
vide a context for activity in Thailand. Over the period of this
study, 228 countries or dependencies worldwide had docu-
mented access and interacted with the FRAX tool website.
As previously reported, the country with the most frequent
access to the FRAX tool website is the USA [14]. Over the
reporting period, around 4.3 million usage sessions were con-
ducted from the USA, followed by the UK (1.3 million) and
Canada (0.3 million) (Table 2). Overall, the correlation (r)
between usage session number and land area was low (r =
0.374, p < 0.001) and that with population size lower still
(r = 0.164, p = 0.011). When usage was adjusted for popula-
tion size, Slovenia showed the highest usage of FRAX (112
usage sessions per 1000 population), followed by Bermuda
(91 usage sessions per 1000 population) and Malta (70 usage
sessions per 1000 population). Within the top ten countries for
absolute numbers of usage sessions listed in Table 2, follow-
ing Slovenia, the highest rates adjusted for the population
were seen in the UK and Sweden. The lowest usage session
rate was seen in Brazil (0.8 usage session per 1000 population)
and an even lower rate was recorded from Thailand (0.5 usage
per 1000 population). A fully detailed account of FRAX ac-
cess from all countries since 2010 is provided in
Supplementary Table 2.
Discussion
Like the developed world in general, Thailand is moving rap-
idly towards an aged society. It is estimated that in 2021, 13
million of the total 65 million population (i.e., 20%) will com-
prise men and women aged 60 years and older; by 2031 [15],
it is predicted that this will rise to 28% of the total population.
The impact that this will have for the burden of fractures has
meant that osteoporosis is now recognised in national health
policy in Thailand in 2018, under a campaign of Brefracture
prevention^ that promotes secondary fracture prevention but
also embraces osteoporosis screening and treatment [16].
Given the low availability of DXA and its relatively high
associated costs (approximately US$ 60 for both lumbar spine
and hip scans), it is highly unlikely that a campaign with DXA
as the first line tool in Thailand would be achievable. In the
UK and other European guidance, clinical risk assessment by
the FRAX tool is advocated as the first line, with DXA mea-
sured BMD targeted to those who lie close to an intervention
threshold [3, 17]. Such an approach shows a more economic
use of scanning resources [18]. The pattern of FRAX usage
over time in Thailand is interesting. For the first 2–3 years of
the study period, a Thailand-specific model of FRAX was not
available and users were advised to undertake calculations
using the Japanese or US Asian tool [8, 19]. It is notable that
the number of regions accessing FRAX increased quite dra-
matically in 2013, coinciding with, but perhaps unrelated to,
Fig. 1 Graph showing the
number of Thailand provinces (77
provinces in total) accessing
FRAX and the number of total
sessions of FRAX accessed from
Thailand, recorded per year
during the current analysis period
(2010–2018)
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Fig. 2 Google Analytics output
of FRAX access and usage across
cities in Thailand over the period
of the study (2010–2018). The
size of the circle reflects the
number of usage episodes
recorded
Table 1 The top ten Thailand provinces accessing the FRAX tool between February 2010 and December 2018, rank by FRAX usage session
Rank Region
(province)
Sessions 2017 population Session per 1000
population





1 Bangkok 41,383 5,682,415 7.3 50.4% 20,521 3.6
2 Khon Kaen 3694 1,805,910 2.0 35.2% 2394 1.3
3 Chiang Mai 3582 1,746,840 2.1 49.6% 1806 1.0
4 Chon Buri 2110 1,509,125 1.4 52.0% 1013 0.7
5 Songkhla 1322 1,424,230 0.9 52.5% 628 0.4
6 Nonthaburi 834 1,229,735 0.7 45.9% 451 0.4
7 Phitsanulok 745 865,368 0.9 46.9% 396 0.5
8 Nakhon Ratchasima 766 2,639,226 0.3 52.4% 365 0.1
9 Nakhon Pathom 638 911,492 0.7 47.3% 336 0.4
10 Samut Prakan 688 1,310,766 0.5 53.5% 320 0.2
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the launch of the Thailand FRAX model. As noted above, the
more rapid increase in actual FRAX usage occurred in line
with updated guidance and a greater focus on the burden of
osteoporosis in 2016/2017 [6]. Importantly, this new osteopo-
rosis management guideline advocated the use of FRAX as a
potential gateway to treatment; even in the absence of a DXA
BMD measurement, as in menopausal woman and men aged
over 50 years old, therapy can be indicated by a 10-year
FRAX Thailand model probability of hip fracture of 3.0% or
greater. Of note, a recent study in the UK that used FRAX as a
population screening tool, in combination with appropriate
intervention in those at high risk of hip fracture, showed a
28% reduction in hip fracture [17, 20].
This retrospective descriptive study shows that the FRAX
website–based tool is accessed worldwide. As expected, this
access varies considerably from country to country; the find-
ing that land area and, more importantly, population size are
only relatively weakly correlated with usage suggests that oth-
er factors impact on FRAX website access. Awareness of os-
teoporosis, availability of resources, and the priority of frac-
ture burden as a local or national healthcare concern are also
likely to be of importance. For example, the availability of
DXA equipment, if regarded as a surrogate measure of the
awareness of osteoporosis and its priority, might be expected
to relate to FRAX usage; Slovenia, the highest user based on
population size, also has one of the highest concentrations of
DXA scanners with 20 per million of the population compared
with for example the UK (8.2 per million) [21]. In Thailand,
where DXA provision is even more limited (0.67 scanners per
million) [22], the FRAX usage is also much lower. It is of
interest, however, that FRAX usage in Thailand is growing
and the potential reasons for this are undoubtedly of interest;
our observation of an approximately 4-fold increase in annual
growth rates for FRAX access that followed the launch of new
national guidelines in late 2016 suggest that national
initiatives and specific guidance on FRAX’s role in risk as-
sessment and management can enhance its usage.
Our study has some limitations. Firstly, the data from
Google Analytics records access to the website, not the actual
fracture risk calculation. Nonetheless, the session rate will still
provide information on the pattern of use over time and across
geographies. We have tried to remove accidental or transient
site access by also analysing the sessions adjusted for the
bounce rate; the patterns are similar though the absolute num-
ber of sessions is decreased. As the website counter embedded
on the FRAXwebsite actually documents full calculations, we
have been able to estimate that there is an approximate ratio of
2.7 between actual calculations and usage (non-bounce) ses-
sions. There is of course the possibility that the use of the
online FRAX calculator may be for purposes other than pa-
tient evaluation and clinical care, for example, research or
other academic purposes. However, it is likely that there is a
correlation between clinical and research use within particular
countries. A further point in the interpretation of high usage
per capita is the impact of the overall population size; for
example, the populations of Bermuda and Malta are relatively
small, ranging from approximately 60,000–400,000, so that
the adoption of FRAX by a relatively small number of clini-
cians can have a significant impact on the per capita use.
Finally, the website is only one source of access to FRAX
calculations; those conducted on densitometers or by a
smartphone app or paper-based systems will not be included
in our analysis.
Conclusion
The FRAX online tool is widely accessed across the world. In
Thailand, the use of FRAX has steadily increased over the
period 2010–2018. A more rapid increase in the last 2 years
Table 2 The top ten countries plus Thailand accessing the FRAX tool between February 2010 and December 2018, rank by FRAX usage session
Rank Country Sessions 2018 population Sessions per
1000 population




1 USA 8,048,970 326,766,748 24.6 47.1% 4,258,344 13.0
2 UK 2,119,471 66,573,504 31.8 37.8% 1,317,755 19.8
3 Canada 646,607 36,953,765 17.5 48.5% 332,875 9.0
4 Spain 476,640 46,397,452 10.3 43.8% 268,052 5.8
5 Slovenia 269,829 2,081,260 129.6 13.8% 232,647 111.8
6 Japan 476,069 127,185,332 3.7 56.9% 205,401 1.6
7 France 312,778 65,233,271 4.8 41.6% 182,794 2.8
8 Sweden 265,260 9,982,709 26.6 35.4% 171,250 17.2
9 Brazil 252,299 210,867,954 1.2 34.0% 166,491 0.8
10 Belgium 280,156 11,498,519 24.4 48.8% 143,426 12.5
35 Thailand 62,353 69,183,173 0.9 49.3% 31,617 0.5
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suggests that its incorporation into national guidance in 2016
enhanced its usage. Further national initiatives to promote
awareness should be strongly considered.
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